The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis
Open accessAbstract
A new myositis-specific autoantibody directed against melanoma differentiation-associated gene 5 (anti-MDA5) has been described in patients with dermatomyositis (DM). We report the clinical characteristics of patients with anti-MDA5 in a large Mediterranean cohort of DM patients from a single center, and analyze the feasibility of detecting this autoantibody in patient sera using new assays with commercially available recombinant MDA5. The study included 117 white adult patients with DM, 15 (13%) of them classified as clinically amyopathic dermatomyositis (CADM). Clinical manifestations were analyzed, with special focus on interstitial lung disease and its severity. Determination of anti-MDA5 antibodies was performed by a new ELISA and immunoblot technique. In sera, from 14 (12%) DM patients (8 CADM), MDA5 was recognized by ELISA, and confirmed by immunoblot. Eight of the 14 anti-MDA5-positive patients (57.14%) presented rapidly-progressive interstitial lung disease (RP-ILD) versus 3 of 103 anti-MDA5-negative patients (2.91%) (P<0.05; OR: 44.4, 95% CI 9.3–212). The cumulative survival rate was significantly lower in anti-MDA5-positive patients than in the remainder of the series (P<0.05). Patients with anti-MDA5-associated ILD presented significantly lower 70-month cumulative survival than antisynthetase-associated ILD patients. Among the cutaneous manifestations, only panniculitis was significantly associated with the presence of anti-MDA5 antibodies (P<0.05; OR: 3.85, 95% CI 1.11–13.27). These findings support the reliability of using commercially available recombinant MDA5 for detecting anti-MDA5 antibodies and confirm the association of these antibodies with RP-ILD in a large series of Mediterranean patients with DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888
Cited by
Classification and management of adult inflammatory myopathies
Selva-O'Callaghan, A., Pinal-Fernandez, I., Trallero-Araguás, E., Milisenda, J. C., Grau-Junyent, J. M., & Mammen, A. L. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30254-0 · Cited by 430
Self-citationSatoh, M., Tanaka, S., Ceribelli, A., Calise, S. J., & Chan, E. K. L. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8510-y · Cited by 420
Tsuji, H., Nakashima, R., Hosono, Y., Imura, Y., Yagita, M., Yoshifuji, H., Hirata, S., Nojima, T., Sugiyama, E., Hatta, K., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41105 · Cited by 357
Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
Nombel, A., Fabien, N., & Coutant, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.773352 · Cited by 262
Kishaba, T., McGill, R., Nei, Y., Ibuki, S., Momose, M., Nishiyama, K., Nagano, H., & Yamashiro, S. (2018) · The Journal of Medical Investigation · doi:10.2152/jmi.65.251 · Cited by 24
Metadata
- Authors
- Labrador-Horrillo, M., Martinez, M. A., Selva-O'Callaghan, A., Trallero-Araguas, E., Balada, E., Vilardell-Tarres, M., & Juárez, C.
- Venue
- Journal of Immunology Research
- Publisher
- Wiley
- Published
- 2014
- Volume
- 2014
- Pages
- 1-8
- ISSN
- 2314-7156 (ISSN-L)
- 2314-8861
- OpenAlex
- W2072206686
- Cited by
- 188
- References
- 1
- FWCI
- 12.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis. https://app.cochat.ai/papers/10.1155/2014/290797
- The paper
- Labrador-Horrillo, M., Martinez, M. A., Selva-O'Callaghan, A., Trallero-Araguas, E., Balada, E., Vilardell-Tarres, M., & Juárez, C. (2014). Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis. Journal of Immunology Research. https://doi.org/10.1155/2014/290797
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.